LLY

1,001.42

+1.23%↑

JNJ

242.77

+0.92%↑

ABBV

228.67

+2.13%↑

NVS

162.22

+1.67%↑

AZN

197.49

+3.56%↑

LLY

1,001.42

+1.23%↑

JNJ

242.77

+0.92%↑

ABBV

228.67

+2.13%↑

NVS

162.22

+1.67%↑

AZN

197.49

+3.56%↑

LLY

1,001.42

+1.23%↑

JNJ

242.77

+0.92%↑

ABBV

228.67

+2.13%↑

NVS

162.22

+1.67%↑

AZN

197.49

+3.56%↑

LLY

1,001.42

+1.23%↑

JNJ

242.77

+0.92%↑

ABBV

228.67

+2.13%↑

NVS

162.22

+1.67%↑

AZN

197.49

+3.56%↑

LLY

1,001.42

+1.23%↑

JNJ

242.77

+0.92%↑

ABBV

228.67

+2.13%↑

NVS

162.22

+1.67%↑

AZN

197.49

+3.56%↑

Home・Stock List・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Open

SectorHealthcare

31.58 4.64

Buy Sell

Overview

Share price change

24h

Current

Min

29.81

Max

31.83

Key metrics
By Trading Economics
Income	-14M -81M
Sales	75K 75K
EPS	-1.22
Profit margin	-108,422.667
Employees	186
EBITDA	-7.8M -81M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+86.54% upside

Dividends
By Dow Jones
Next Earnings	6 May 2026

Market Stats
By TradingEconomics
Market Cap	377M 2B
Previous open	26.94
Previous close	31.58

News Sentiment

By Acuity

50%

145 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

18.91 / 20.63 Support & Resistance

Celldex Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

9 Mar 2026, 18:13 UTC

Acquisitions, Mergers, Takeovers

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9 Mar 2026, 17:20 UTC

Major News Events

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9 Mar 2026, 17:15 UTC

Acquisitions, Mergers, Takeovers

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10 Mar 2026, 00:00 UTC

Major News Events

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9 Mar 2026, 23:52 UTC

Market Talk

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9 Mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9 Mar 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 Mar 2026, 23:46 UTC

Market Talk

Major News Events

Correction to Crude Prices Market Talk on March 9

9 Mar 2026, 23:42 UTC

Market Talk

Major News Events

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9 Mar 2026, 23:08 UTC

Major News Events

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9 Mar 2026, 23:07 UTC

Major News Events

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9 Mar 2026, 21:29 UTC

Acquisitions, Mergers, Takeovers

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9 Mar 2026, 21:28 UTC

Acquisitions, Mergers, Takeovers

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9 Mar 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 Mar 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9 Mar 2026, 20:47 UTC

Major News Events

The 24 Hours When Oil Markets Went Wild -- WSJ

9 Mar 2026, 20:33 UTC

Major News Events

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9 Mar 2026, 20:14 UTC

Market Talk

Major News Events

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9 Mar 2026, 19:33 UTC

Major News Events

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9 Mar 2026, 19:17 UTC

Market Talk

Major News Events

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9 Mar 2026, 19:14 UTC

Market Talk

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9 Mar 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

9 Mar 2026, 18:23 UTC

Market Talk

Major News Events

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9 Mar 2026, 17:58 UTC

Acquisitions, Mergers, Takeovers

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9 Mar 2026, 17:57 UTC

Acquisitions, Mergers, Takeovers

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9 Mar 2026, 17:41 UTC

Major News Events

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9 Mar 2026, 17:41 UTC

Market Talk

Major News Events

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9 Mar 2026, 17:08 UTC

Market Talk

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9 Mar 2026, 17:04 UTC

Market Talk

Major News Events

Global Forex and Fixed Income Roundup: Market Talk

9 Mar 2026, 17:04 UTC

Market Talk

Major News Events

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Peer Comparison

Price change

Celldex Therapeutics Inc Forecast

Price Target

By TipRanks

86.54% upside

12 Months Forecast

Average 54.9 USD 86.54%

High 90 USD

Low 24 USD

Based on 11 Wall Street analysts offering 12 month price targets forCelldex Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Celldex Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

18.91 / 20.63Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

145 / 351 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.